Assembly Biosciences (ASMB) Common Equity (2010 - 2026)
Assembly Biosciences (ASMB) reported Common Equity of $305.65 million for Q2 2026, compared with $18.1 million a year earlier and up 53.9% from the prior quarter.
Powered by 
Analysis
Assembly Biosciences (ASMB) Common Equity (2010 - 2026) Analysis & Trends
At the end of FY2025, Assembly Biosciences posted Common Equity of $206.75 million, up 519.8% from FY2024.
- Common Equity has a five-year compound annual growth rate of -3.0% (FY2020 to FY2025).
- By year, Common Equity came in at $33.36 million in FY2024 (-18.8%), $41.1 million in FY2023 (-50.3%), $82.66 million in FY2022 (-51.1%) and $168.93 million in FY2021 (-29.8%).
- The Q2 2026 figure ranks as the highest quarterly Common Equity in data going back to Q4 2010.
- Year over year, Common Equity gained in three of the last seven quarters, with growth averaging 233.3%.
- The high point for year-over-year Common Equity in five years was Q1 2026 (growth of 632.0%); the low point was Q3 2023 (a decline of 59.3%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $198.61 million (Q1 2026), $206.75 million (Q4 2025) and $182.7 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 84.97 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | -5.94 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 41.98 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 41.95 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 50.37 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 11.69 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 11.83 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 85.49 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 20.25 Bn |
| 10 | Assembly Biosciences | 468.67 Mn | -558.96 Mn | - | 305.65 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 305.65 Mn |
| Mar 31, 2026 | 198.61 Mn |
| Dec 31, 2025 | 206.75 Mn |
| Sep 30, 2025 | 182.70 Mn |
| Jun 30, 2025 | 18.10 Mn |
| Mar 31, 2025 | 27.13 Mn |
| Dec 31, 2024 | 33.36 Mn |
| Sep 30, 2024 | 26.00 Mn |
| Jun 30, 2024 | 34.68 Mn |
| Mar 31, 2024 | 32.60 Mn |
| Dec 31, 2023 | 41.10 Mn |
| Sep 30, 2023 | 41.71 Mn |
| Jun 30, 2023 | 54.95 Mn |
| Mar 31, 2023 | 70.33 Mn |
| Dec 31, 2022 | 82.66 Mn |
| Sep 30, 2022 | 102.40 Mn |
| Jun 30, 2022 | 123.98 Mn |
| Mar 31, 2022 | 146.79 Mn |
| Dec 31, 2021 | 168.93 Mn |
| Sep 30, 2021 | 224.65 Mn |
API Access
Assembly Biosciences Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=ASMB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "ASMB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=ASMB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();